4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001193125-25-322740
Chief Legal Officer sold 3,452 shares at $12.92 ($44,600)
From the SEC's structured data for this filing
Trades in this filing
Oltmans Curtis Gale · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-15 | Sale : show line 1 in the form | −3,452 | $12.92 | $44,600 | 10,252 | D |
| Open-market sales · 3,452 sh · avg $12.92 · $44,600 | ||||||
Loading xslF345X05/ownership.xml…